000 | 01221 a2200361 4500 | ||
---|---|---|---|
005 | 20250516141707.0 | ||
264 | 0 | _c20140227 | |
008 | 201402s 0 0 eng d | ||
022 | _a1365-2710 | ||
024 | 7 |
_a10.1111/jcpt.12058 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOztekin, O | |
245 | 0 | 0 |
_aChemotherapy for transient myeloproliferative disorder in a premature infant with Down syndrome. _h[electronic resource] |
260 |
_bJournal of clinical pharmacy and therapeutics _cJun 2013 |
||
300 |
_a262-4 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aDown Syndrome _xcomplications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 | _aInfant, Premature |
650 | 0 | 4 |
_aMyeloproliferative Disorders _xdiagnosis |
700 | 1 | _aKalay, S | |
700 | 1 | _aTezel, G | |
700 | 1 | _aTayfun, F | |
700 | 1 | _aKupesiz, A | |
700 | 1 | _aHangul, M | |
700 | 1 | _aAkcakus, M | |
700 | 1 | _aOygur, N | |
773 | 0 |
_tJournal of clinical pharmacy and therapeutics _gvol. 38 _gno. 3 _gp. 262-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/jcpt.12058 _zAvailable from publisher's website |
999 |
_c22597030 _d22597030 |